Biosimilars LATAM Regulations

16th & 17th November 2017,
Mexico City

Biosimilars LATAM Regulations

16th & 17th November 2017, Mexico City

bio-guru-vision.svg
Discussions
Interactive discussion with regulatory agencies in seek for consolidated regulations
bio-network.svg
Updates
New guidelines in Europe. The Latam’s reference region update.
bio-hot-toics.svg
Advices
Ask to HCPs and Patients for advice to develop your strategies
bio-new-markets.svg
Fresh views
C-level executive panel outlook on the future of Biosimilars in Latam

Summary

The regulation of similar bio-therapeutic products in Latin America varies widely among different countries, from some countries that are yet to introduce their own regulation to Brazil and Mexico that have in place paths which help patients access to cheaper but still complex and safe biologic treatments.
However, there is still a lot to improve and experience for a mature Latam Biosimilars market.Biosimilars LATAM Regulations 2017 is an exclusive and imperative meeting point where all valuable information and experiences are shared to help the Latin American Pharmaceutical Industry move into a dynamic and faster growth inside the biosimilars market.
Join us in Mexico and be part of the evolution in the Latin American Healthcare!

100+ Attendees | 10+ Key interactions | 15+ Topics

Why to attend?

  • Get the latest Regulatory updates from Cofepris, Anvisa, Invima & Anmat and understand their ambitious plans for biosimilars approval process in their countries.
  • Learn from real case studies and second-hand experiences throughout industry challenges and its solutions in the development and registration of biosimilars.
  • Identify opportunities on the market
  • Gather the know-how and use the practical knowledge shared at the forum in your company to improve any business strategies.
  • Escalate your visibility within the industry by being part of the open discussions.

Who will you meet?

Government institutions, Health care Professionals and patient associations.
CEOs / COOs / Directors / VPs / Bio-technologists / Managing Directors / Managers and Specialists from:

  • Biosimilars, Biobetters, Biotechnology, Biotherapeutics, Analytical science, Regulatory compliance, Quality control, Clinical immunology, Scientific affairs, Pharmacology, Pharmacovigilance

Speakers

Adilson Montaneira

Adilson Montaneira

Pfizer | Brazil | Business Unit Director – BIOSIMILAR
Emilio Medina Rivero

Emilio Medina Rivero

UDIBI | Mexico | Technical-Scientific Director
Francisco Cruz Rodriguez

Francisco Cruz Rodriguez

biolex corp. | Mexico | Fundador e Investigador Read More
Francisco Cuauhtémoc Perdomo

Francisco Cuauhtémoc Perdomo

Springfield Biotech | Mexico | Analytical Scientist Manager Read More
  • 1
  • 2
  • 3
  • 4
  • 5

Speaking Companies

Speaking Companies

Speaking Companies

Speaking Companies

Speaking Companies

Speaking Companies

Program

1st day

Regulations update
from Cofepris, Anvisa, Invima & Anmat representatives
Panel discussion
Update on clinical trial designs for biosimilars
How fast and broad will the entry of Biosimilars be in Latam?
Biological and physicochemical challenges of biosimilars in Mexico
Synthetic Biology and Systems Biology:
Cocktail meeting

2nd day

HCP’s talk on:
the real situation of Biosimilars in Latam
HCP’s & Patients' recommendations on:
Chit-chat on:
Case study:
Best practices debate on:
Clinical research aspects:
Expert panel debate on:

Association Partner

Association Partner

Association Partner

Association Partner

Media Partner

Association Partner

Media Partner

Media Partner of Jack Leckerman

Media Partner

Media Partner of Jack Leckerman

Keep me updated

About "Jack Leckerman"

Jack Leckerman Company has been established as a business intelligence event services and the promotion of global summits, strategic conferences, open forums and professional training.

©2017 Jack Leckerman. All Rights Reserved. Designed By

Search